Pieters R - Search Results

1

L-Asparaginase and the effect of age on coagulation and fibrinolysis in childhood acute lymphoblastic leukemia.

Appel IM, Hop WC, van Kessel-Bakvis C, Stigter R, Pieters R. Appel IM, et al. Among authors: pieters r. Thromb Haemost. 2008 Aug;100(2):330-7. Thromb Haemost. 2008. PMID: 18690355 Clinical Trial.

2

Value of routine bone marrow examination for detection of bone marrow relapse in children with standard risk acute lymphoblastic leukemia.

Haumann TJ, van Wering ER, van der Does-van den Berg A, Pieters R, Huisjes AJ, Veerman AJ. Haumann TJ, et al. Among authors: pieters r. Pediatr Hematol Oncol. 1992 Jan-Mar;9(1):41-7. doi: 10.3109/08880019209006395. Pediatr Hematol Oncol. 1992. PMID: 1558775

3

Topoisomerase II alpha gene expression in childhood acute lymphoblastic leukemia.

Klumper E, Giaccone G, Pieters R, Broekema G, van Ark-Otte J, van Wering ER, Kaspers GJ, Veerman AJ. Klumper E, et al. Among authors: pieters r. Leukemia. 1995 Oct;9(10):1653-60. Leukemia. 1995. PMID: 7564505

4

In vitro cellular drug resistance in children with relapsed/refractory acute lymphoblastic leukemia.

Klumper E, Pieters R, Veerman AJ, Huismans DR, Loonen AH, Hählen K, Kaspers GJ, van Wering ER, Hartmann R, Henze G. Klumper E, et al. Among authors: pieters r. Blood. 1995 Nov 15;86(10):3861-8. Blood. 1995. PMID: 7579354 Free article.

5

Drug combination testing in acute lymphoblastic leukemia using the MTT assay.

Kaspers GJ, Veerman AJ, Pieters R, Van Zantwijk I, Hählen K, Van Wering ER. Kaspers GJ, et al. Among authors: pieters r. Leuk Res. 1995 Mar;19(3):175-81. doi: 10.1016/0145-2126(94)00126-u. Leuk Res. 1995. PMID: 7700079

6

Favorable prognosis of hyperdiploid common acute lymphoblastic leukemia may be explained by sensitivity to antimetabolites and other drugs: results of an in vitro study.

Kaspers GJ, Smets LA, Pieters R, Van Zantwijk CH, Van Wering ER, Veerman AJ. Kaspers GJ, et al. Among authors: pieters r. Blood. 1995 Feb 1;85(3):751-6. Blood. 1995. PMID: 7833478 Free article.

7

Different cellular drug resistance profiles in childhood lymphoblastic and non-lymphoblastic leukemia: a preliminary report.

Kaspers GJ, Kardos G, Pieters R, Van Zantwijk CH, Klumper E, Hählen K, de Waal FC, van Wering ER, Veerman AJ. Kaspers GJ, et al. Among authors: pieters r. Leukemia. 1994 Jul;8(7):1224-9. Leukemia. 1994. PMID: 8035616

8

Cellular drug resistance in childhood leukemia.

Veerman AJ, Kaspers GJ, Pieters R. Veerman AJ, et al. Among authors: pieters r. Ann Hematol. 1994;69 Suppl 1:S31-4. doi: 10.1007/BF01757352. Ann Hematol. 1994. PMID: 8061109 Review.

9

Clinical relevance of in vitro drug resistance testing in childhood acute lymphoblastic leukemia: the state of the art.

Pieters R, Kaspers GJ, Klumper E, Veerman AJ. Pieters R, et al. Med Pediatr Oncol. 1994;22(5):299-308. doi: 10.1002/mpo.2950220502. Med Pediatr Oncol. 1994. PMID: 8127253

10

Cellular drug sensitivity of immunophenotypic subgroups of childhood acute lymphoblastic leukemia.

Pieters R, Kaspers GJ, van Wering ER, Huismans DR, Loonen AH, Hählen K, Veerman AJ. Pieters R, et al. Recent Results Cancer Res. 1993;131:249-56. doi: 10.1007/978-3-642-84895-7_22. Recent Results Cancer Res. 1993. PMID: 8210644 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,016 results

Search Page

Filters